FDA Antimicrobial Development Draft Guidances Withdrawn Under Rejuvenation Initiative
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA says the 13 guidances are out of date and of no use to industry; a number of others covering various topics also will be revised or finalized.